1. Home
  2. PYN vs CGTX Comparison

PYN vs CGTX Comparison

Compare PYN & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PYN
  • CGTX
  • Stock Information
  • Founded
  • PYN 2002
  • CGTX 2007
  • Country
  • PYN United States
  • CGTX United States
  • Employees
  • PYN N/A
  • CGTX N/A
  • Industry
  • PYN Investment Managers
  • CGTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • PYN Finance
  • CGTX Health Care
  • Exchange
  • PYN Nasdaq
  • CGTX Nasdaq
  • Market Cap
  • PYN 33.5M
  • CGTX 30.0M
  • IPO Year
  • PYN N/A
  • CGTX 2021
  • Fundamental
  • Price
  • PYN $5.76
  • CGTX $0.61
  • Analyst Decision
  • PYN
  • CGTX Strong Buy
  • Analyst Count
  • PYN 0
  • CGTX 6
  • Target Price
  • PYN N/A
  • CGTX $8.30
  • AVG Volume (30 Days)
  • PYN 19.9K
  • CGTX 847.4K
  • Earning Date
  • PYN 01-01-0001
  • CGTX 03-25-2025
  • Dividend Yield
  • PYN 5.07%
  • CGTX N/A
  • EPS Growth
  • PYN N/A
  • CGTX N/A
  • EPS
  • PYN N/A
  • CGTX N/A
  • Revenue
  • PYN N/A
  • CGTX N/A
  • Revenue This Year
  • PYN N/A
  • CGTX N/A
  • Revenue Next Year
  • PYN N/A
  • CGTX N/A
  • P/E Ratio
  • PYN N/A
  • CGTX N/A
  • Revenue Growth
  • PYN N/A
  • CGTX N/A
  • 52 Week Low
  • PYN $4.84
  • CGTX $0.34
  • 52 Week High
  • PYN $6.60
  • CGTX $2.95
  • Technical
  • Relative Strength Index (RSI)
  • PYN 47.28
  • CGTX 37.49
  • Support Level
  • PYN $5.68
  • CGTX $0.60
  • Resistance Level
  • PYN $5.89
  • CGTX $0.68
  • Average True Range (ATR)
  • PYN 0.04
  • CGTX 0.06
  • MACD
  • PYN 0.01
  • CGTX -0.02
  • Stochastic Oscillator
  • PYN 38.10
  • CGTX 2.62

About PYN PIMCO New York Municipal Income Fund III of Beneficial Interest

PIMCO New York Municipal Income Fund III is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State, and New York City income tax. To pursue the objectives, the fund invests a majority of its net assets in municipal bonds that pay interest that is exempt from federal, New York State, and New York City income tax.

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

Share on Social Networks: